Efficient in-situ synthesis of heterocyclic derivatives from benzyl alcohols using pyrazinium chlorochromate-functionalized carbonitride as a novel catalyst.

Hasan Soltani, Zeinab Tajik, Zahra Nasri, Peyman Hanifehnejad, Elaheh Hamidi, Zahra Aslbeigi, Hossein Ghafuri

Abstract read

In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

CuO stabilized on magnetic decorated GO nanosheets for efficient synthesis of 3,4-dihydropyrimidine-2(1H)-one/thione and 1,4-dihydropyridine derivatives under green conditions.Scientific reports · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hasan SoltaniCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran.

Zeinab TajikCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran.

Zahra NasriCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran.

Peyman HanifehnejadCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran.

Elaheh HamidiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran.

Zahra AslbeigiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran.

Hossein GhafuriCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, 16846-13114, Iran. ghafuri@iust.ac.ir.

Funding

Catalysts and Organic Synthesis Research Laboratory Hossein ghafuri

6 · The paper itself

Abstract

The synthesis of efficient organic compounds from simple substrates is both noticeable and important. However, it can be challenging to achieve this target using suitable strategies. To address this issue, pyrazinium chlorochromate (PCC) was used to modify carbonitride nanosheets (CNs) and applied as a heterogeneous catalyst in the oxidation of benzyl alcohols. That can be regarded as innovation in ingenious synthesis of the PCC on the CNs. Then, it was identified by varied techniques such as EDS, FT-IR, XRD, STA and FE-SEM. This process resulted in in-situ synthesis of 1,4-dihydropyridine and 3,4-dihydropyrimidin-2-(1H) one derivatives with excellent yield.

Indexed as

1,4-dihydropyridine3,4-dihydropyrimidin-2-(1H)-oneCNs@PCCHeterogeneous catalyst

Identifiers

PMID39402312

DOI10.1007/s10562-020-03371-0

PMCPMC11473725

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.